22 citations
,
November 2002 in “Clinical journal of oncology nursing” This article discusses arsenic trioxide as a treatment for refractory or relapsed acute promyelocytic leukemia, noting its effectiveness and manageable side effects.
9 citations
,
September 2010 in “Journal of Radioanalytical and Nuclear Chemistry” The woman likely died from acute arsenic poisoning, not chronic exposure.
1 citations
,
February 2002 in “Oncology Times” This research reports that arsenic trioxide achieved a complete remission rate of 87% in patients with relapsed acute promyelocytic leukemia, though its use involves manageable toxicities.
5 citations
,
January 2004 in “Biochimie” This review discusses arsenic trioxide therapy in acute promyelocytic leukemia and introduces a novel method using hair analysis to monitor arsenic exposure and correlate it with treatment timing, but reports no new clinical results.
This review discusses fractionated reirradiation as a potential treatment for recurrent brain tumors in children and highlights ongoing challenges with managing craniospinal dissemination; it provides no new clinical results.